(精选)CARDIOVASCULAR DISEASE AND LIPIDS IN DIABETES教学课件.pptVIP

Coronary artery disease, Hypertension and Lipids In Diabetes ;Case 1; On examination his BP was 100/60 mm Hg, had crepts over lung base and absent right leg pulse. ECG showed fully evolved MI with Q-waves in the anterolateral leads. RBS was 326 mg/dl and urine ketone was trace positive. ;Case 2;The problem…;What is different with diabetes ?; the difference…;;Further evaluation ;Glycaemic control – CAD;Hypertension -the problem statement ;How crucial is BP control ?;What is the target BP?;Non-pharmacological management;Pharmacotherapy of hypertension; When to start therapy?;Special situations;Cardio protective drugs;Surgical intervention;;Kolovo GD. Postgrad Med J. 2005;81;358-366.;?VLDL;“Atherogenic Dyslipidemia” (=Dyslipidemia of Diabetes Mellitus/ Insulin Resistance);NCEP Guidelines-TG and Non–HDL-C as Important Parameters for Lipid Management;Non-HDL Includes All Atherogenic Lipoprotein Classes;;;Management of dyslipidemia;Drugs available:;Dietary modification;Management of dyslipidemia;Statin therapy;*;;Cholesterol Treatment Trialist Collaboration Findings;Fenofibrate ;*;*;*;*;*;*;*;Agents That Raise HDL-C;Monitoring